| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |